U-Blot® Research Grade LibivirumabCat. No. WA3076$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade LibivirumabCat. No. WA3076
U-Blot® Research Grade LibevitugCat. No. WA3075
U-Blot® Research Grade lexucitugCat. No. WA3074
U-Blot® Research Grade LexatumumabCat. No. WA3073
U-Blot® Research Grade LevilimabCat. No. WA3072
U-Blot® Research Grade LeukotuximabCat. No. WA3071
U-Blot® Research Grade LetolizumabCat. No. WA3070
U-Blot® Research Grade LetaplimabCat. No. WA3069
U-Blot® Research Grade LesofavumabCat. No. WA3068
U-Blot® Research Grade LesigerceptCat. No. WA3067
U-Blot® Research Grade LesabelimabCat. No. WA3066
U-Blot® Research Grade LeronlimabCat. No. WA3065